BLISS GVS PHARMA
|
The Current P/S Ratio of BLISS GVS PHARMA is 2.08.
| Share Price | ₹169.6 | Nov 24,2025 |
| Market Cap | ₹1,792.1 Cr | |
| Sales-TTM | ₹860.3 Cr | TTM-Consolidated Results |
| Price/Sales | 2.08x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of BLISS GVS PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹1,792.1 Cr] as on Nov 24,2025
(/) Sales [ ₹860.3 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.08x ]
Thus, for BLISS GVS PHARMA , the investors are currently willing to pay '2.08 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of BLISS GVS PHARMA !
The chart below summarizes the trend in P/S Ratio of BLISS GVS PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of BLISS GVS PHARMA
PS Ratio Performance Analysis for BLISS GVS PHARMA
- BLISS GVS PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.38x.
- BLISS GVS PHARMA 's operated at median p/e ratio of 1.53x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BLISS GVS PHARMA 's p/e ratio peaked in Mar2021 at 1.76x.
- BLISS GVS PHARMA 's p/e ratio hit its five-year low in Mar2023 of 0.99x.
How does BLISS GVS PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| BLISS GVS PHARMA | 860.3 | 2.08 | 1,792.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 7.78 | 427,370.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 16.83 | 168,802.0 |
| CIPLA LTD | 28,349.6 | 4.29 | 121,481.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 10.27 | 125,841.0 |
| DR REDDYS LABORATORIES LTD | 34,310.0 | 2.98 | 102,220.0 |
| MANKIND PHARMA LTD | 13,576.9 | 6.75 | 91,632.4 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.81 | 93,237.6 |
| LUPIN LTD | 24,750.7 | 3.69 | 91,293.1 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.13 | 69,365.1 |
| ABBOTT INDIA LTD | 6,714.4 | 9.41 | 63,159.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs BLISS GVS PHARMA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.08x |
| Max industry PS | 16.83x |
| Median industry PS | 4.29x |
| Average industry PS | 6.36x |
You may also like the below Video Courses